FVII-targeting significantly improved not only the effectiveness and but also the selectivity of non-targeted PDT effect in killing lung and breast cancer cells and angiogneic vascular endothelial cells in vitro [15, 20], all of which expressed TF. The gene discussed is TF; the disease is breast cancer.